Le Lézard
Classified in: Health, Business
Subjects: PER, CXP

Dr. Alexander Song Joins Los Angeles Cancer Network


LOS ANGELES, Aug. 3, 2023 /PRNewswire/ -- Los Angeles Cancer Network (LACN), one of the leading cancer and blood disorder centers in Los Angeles, is proud to announce that Alexander Song, MD has officially joined its growing network. He will be practicing at LACN's Hollywood Presbyterian [1300 N. Vermont Ave. Los Angeles, CA 90027] and Good Samaritan [1245 Wilshire Blvd. Suite 303, Los Angeles, CA 90017] clinics.

"We are thrilled to have Dr. Song join our team," said Troy Simon, LACN's CEO.
"We look forward to him integrating into our Downtown and Hollywood patient communities."

Dr. Alexander Song completed his medical education at Eastern Virginia Medical School. He continued to achieve his residency in internal medicine at Wake Forest Baptist Medical Center in Winston Salem, North Carolina. He decided to pursue medical oncology & hematology as a specialty and completed his fellowship at Wake Forest Baptist Comprehensive Cancer Center in Winston Salem, NC, where he served as Chief Fellow.

Dr. Song is committed to providing the highest quality care to his patients. He has extensive research background with a focus on immunotherapy.

"I am excited to join Los Angeles Cancer Network," said Dr. Song, "because I will be able to provide compassionate and individualized care, work next to some of the best physicians in the nation and have access to cutting-edge clinical trials so I can better serve my patients. I look forward to getting to know the community."

Dr. Song is fluent in English and Korean.

To make an appointment with Dr. Song, please call (323) 760-9757. For more information, visit lacancernetwork.com.

About Los Angeles Cancer Network: 

The mission of Los Angeles Cancer Network is to provide unparalleled care to each patient that comes through our doors. We offer individualized treatment using the most recent and relevant proven advances in cancer care, curated with deliberation and compassion.

SOURCE Los Angeles Cancer Network


These press releases may also interest you

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...



News published on and distributed by: